Search results :

Gadolinium

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Discomfort 26.4% x x x
Dysgeusia 0.4% - 6.2% x x x x x x x
Dizziness 0.5% - 3.74% x x x x x x
Paraesthesia 0.1% - 2.22% x x x x x x x
Diarrhoea postmarketing, 1.91% x x x
Asthenia 1.53% x
Rhinitis postmarketing, 1.53% x x
Headache 0.5% - 9.4% x x x x x x x
Nausea 0.6% - 3.21% x x x x x x x
Back pain 0.6% - 1.22% x x
Dyspepsia 1.22% x
Pain postmarketing, 0.4% - 1.83% x x x
Body temperature increased postmarketing, 0.9% x x x
Vomiting 0.3% - 1.4% x x x x x x
Injection site reaction postmarketing, 0.3% - 1.53% x x x x x x
Injection site pain 0.4% x
Coldness 0.4% x
Feeling hot 0.4% - 0.8% x x x x
Rash 0.3% x x x x x
Flushing 0.3% x x x
Dyspnoea 0.2% x x x x x
Fatigue 0.2% x x
Pruritus 0.2% - 0.3% x x x x x x x
Erythema 0.2% x x
Respiratory distress 0.2% x
Injection site coldness 0.2% x
Vertigo 0.1% x x x
Dry mouth 0.1% x x x x x
Chills 0.1% x x
Feeling abnormal 0.1% x
Abdominal pain postmarketing x x
Anaphylactic shock postmarketing x x
Angioedema postmarketing x x x
Arrhythmia postmarketing x x
Blister postmarketing x
Bronchospasm postmarketing x x x
Chest pain postmarketing, 0.1% x x x x x
Coma postmarketing x
Conjunctivitis postmarketing x x x x x
Connective tissue disorder postmarketing x x
Muscle contracture postmarketing x
Cough postmarketing x x x x
Cyanosis postmarketing x x x
Oedema postmarketing x x
Extravasation postmarketing, 0.4% x x x
Gastrointestinal disorder postmarketing x x
Cardiac arrest postmarketing x x x
Cardiac disorder postmarketing x x
Hyperhidrosis postmarketing, 0.9% x x x x x
Hypersensitivity postmarketing, 0.2% x x x x x x x
Hypoaesthesia postmarketing x x
Hypotension postmarketing x x x x
Immune system disorder postmarketing x x
Laryngeal oedema postmarketing x x
Laryngospasm postmarketing x x x
Necrosis postmarketing x
Nervous system disorder postmarketing x x
Pallor postmarketing x x x x
Pulmonary oedema postmarketing x x x
Convulsion postmarketing x x x x
Shock postmarketing x x x
Salivary hypersecretion postmarketing x x x
Sneezing postmarketing x x x x
Swelling postmarketing x
Syncope postmarketing x x
Tachycardia postmarketing x x x x x
Tremor postmarketing x x x x
Loss of consciousness postmarketing x x x
Urticaria postmarketing x x x x x x
Angiopathy postmarketing x
Burning sensation postmarketing, 0.2% x x x x x
Agitation postmarketing x x
Muscular weakness postmarketing x
Lacrimation increased postmarketing x
Ocular hyperaemia postmarketing x x
Eyelid oedema postmarketing x x x
Respiratory arrest postmarketing x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x
Malaise postmarketing x x x x x x
Pharyngeal oedema postmarketing x
Anaphylactoid reaction postmarketing x x x x x x
Bradycardia postmarketing x
Blood pressure increased postmarketing, 0.4% x x x
Face oedema postmarketing x x x x
Presyncope postmarketing x
Phlebitis superficial postmarketing x
Oropharyngeal swelling postmarketing x x
Parosmia postmarketing, 0.3% x x x x x x
Nephrogenic systemic fibrosis postmarketing x x x x x
Amblyopia x
Anorexia x
Anxiety x x
Arthralgia x
Asthma x
Bundle branch block x
Neck pain x
Confusional state x
Constipation x
Dysphagia x
Depersonalisation x
Diplopia x
Dysuria x
Epistaxis x
Eructation x
Erythema multiforme x
Eye disorder x
Flatulence x
Glioma x
Hallucination x
Haemoptysis x
Hypercalcaemia x
Hyperglycaemia x
Hypertension x x x
Hypoglycaemia x
Hyponatraemia x
Inflammation x
Eye pruritus x
Cramps of lower extremities x
Mediastinal disorder x
Hypertonia x
Nasal congestion x
Nervousness x
Numbness x
Oliguria x
Pain in extremity x
Palpitations x x x x x
Pelvic pain x
Pharyngitis x
Hyperacusis x
Sinusitis x
Muscle spasms x
Thirst x
Thrombocytopenia x
Thrombophlebitis x
Tinnitus x
Wheezing x
Atrioventricular block first degree x
Vasospasm x
Neck stiffness x
Application site reaction x
Creatinine increased x
Swelling face x
Injection site swelling x
Tongue oedema x
Injection site inflammation x
Dry skin x
Rash macular x
Myalgia x x
Increased appetite x
Lip swelling x
Pancreatitis necrotising x
Eye swelling x
Akathisia x
Warmth x
Oral discomfort x
Rash maculo-papular x
Injection site bruising x
Paraesthesia oral x
Visual disturbance x
Serum creatinine increased x
Sweating increased x
Basophilia x
Blood and lymphatic system disorders x
Venipuncture site bruise x
Myasthenia x
Oropharyngeal discomfort x
Acute kidney injury x
Somnolence x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

GADOLINIUM CATION (3+)

Side effects:15
Source:FDA Structured Product Label

GADOLINIUM CATION (3+)

Side effects:43
Source:FDA Structured Product Label

GADOLINIUM CATION (3+)

Side effects:44
Source:FDA Structured Product Label

GADOLINIUM CATION (3+)

Side effects:52
Source:FDA Structured Product Label

GADOLINIUM CATION (3+)

Side effects:62
Source:FDA Structured Product Label

GADOLINIUM CATION (3+)

Side effects:62
Source:FDA Structured Product Label

GADOLINIUM CATION (3+)

Side effects:89
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label